Want to join the conversation?
$MCK said it will own about 70% of the new company, with the remaining equity stake held by Change Healthcare Holdings' stockholders, which include $BX and Hellman & Friedman. The transaction is expected to generate in excess of $150MM in annual synergies by the second year following close of transaction, which is likely in calendar 1H17.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.